Global Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market Size study & Forecast, by Products (Instruments, Consumables), by End-use (Clinical Laboratory, Point-of-care) and Regional Forecasts 2025-2035

The Global Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market, valued at approximately USD 2.88 billion in 2024, is projected to expand at a CAGR of over 4.50% during the forecast period from 2025 to 2035. Blood gas analyzers, along with electrolyte analyzers, are pivotal diagnostic instruments used in measuring blood gases, pH, and electrolytes—essential for evaluating a patient’s respiratory and metabolic state. These devices are indispensable in intensive care units, operating theaters, emergency rooms, and clinical laboratories where rapid and accurate results can influence life-saving decisions. Market expansion is underpinned by the rising prevalence of chronic diseases such as COPD, cardiovascular disorders, and diabetes, which increase hospital admissions and demand for continuous patient monitoring. Additionally, the growing geriatric population and the heightened emphasis on early diagnosis are driving the adoption of these analyzers globally.

The surge in demand for point-of-care testing solutions has significantly fueled market growth, as healthcare systems worldwide pivot toward decentralized diagnostics to improve patient outcomes and reduce turnaround times. According to WHO, non-communicable diseases account for over 70% of all global deaths, creating sustained demand for rapid and precise diagnostic tools. Technological advancements—such as portable, user-friendly devices with integrated data connectivity—are revolutionizing the blood gas analysis landscape, enabling faster clinical decision-making. Moreover, the integration of multiplex testing capabilities into compact platforms is opening new avenues for their deployment beyond traditional hospital settings, including ambulatory care and home healthcare environments. Nonetheless, high device costs, stringent regulatory frameworks, and the need for skilled operators may moderate market expansion in certain regions.

Geographically, North America is expected to retain a dominant share of the market in 2025, underpinned by its advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and strong presence of leading diagnostic equipment manufacturers. The region’s favorable reimbursement policies and growing burden of respiratory and metabolic diseases further support market penetration. Europe follows closely, driven by well-established healthcare systems, an aging population, and robust investments in critical care diagnostics. Meanwhile, Asia Pacific is anticipated to witness the fastest growth during the forecast period, propelled by expanding healthcare access in emerging economies, rapid hospital infrastructure development, and government-led initiatives to enhance diagnostic capabilities. Countries such as China and India are witnessing a surge in demand for both instruments and consumables, particularly in high-volume clinical laboratories and newly established point-of-care testing facilities.

Major market player included in this report are:
• Siemens Healthineers AG
• Radiometer Medical ApS
• Abbott Laboratories
• Instrumentation Laboratory (Werfen)
• Medica Corporation
• Nihon Kohden Corporation
• Edan Instruments, Inc.
• Perlong Medical Equipment Co., Ltd.
• OPTIMEDICAL Systems Inc.
• F. Hoffmann-La Roche Ltd.
• Convergent Technologies GmbH & Co. KG
• Erba Mannheim
• Samsung Medison Co., Ltd.
• Nova Biomedical
• Mindray Medical International Limited

Global Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Products:
• Instruments
• Consumables

By End-use:
• Clinical Laboratory
• Point-of-care

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more